The Impact of Liquid Biopsies Positive for EGFR Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients

In recent years, non-small cell lung cancer treatment has been revolutionized. EGFR tyrosine kinase inhibitors and our improved understanding of its alterations have driven new diagnostic strategies. Liquid biopsies have emerged as a useful tool in these contexts, showing potential utility in early...

Descripción completa

Detalles Bibliográficos
Autores principales: Roldan Ruiz, Jonnathan, Fuentes Gago, Marta Gracia, Chinchilla Tabora, Luis Miguel, Gonzalez Morais, Idalia, Sayagués, José María, Abad Hernández, Mar, Cordovilla Pérez, Maria Rosa, Ludeña de la Cruz, Maria Dolores, del Barco Morillo, Edel, Rodriguez Gonzalez, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377956/
https://www.ncbi.nlm.nih.gov/pubmed/37510091
http://dx.doi.org/10.3390/diagnostics13142347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377956/
https://www.ncbi.nlm.nih.gov/pubmed/37510091
http://dx.doi.org/10.3390/diagnostics13142347

Ejemplares similares